Blog

The case for establishing a minimal medication alternative for psychosis and schizophrenia

A new article in the journal Psychosis examines whether everyone with a psychotic condition needs long-term antipsychotic treatment and evidence for alternative models of care. The article recommends that healthcare providers should be encouraged to develop a psychosocial treatment package for people with psychosis or schizophrenia that provides a realistic possibility of minimising antipsychotic exposure. …

Stories of Reducing Antipsychotics: withdrawal effects or relapse?

The RADAR Study team are hosting an online webinar on Wednesday 9th June, 2-3:30pm BST, exploring lived experience perspectives on attempting to distinguish withdrawal effects from relapse, when reducing antipsychotics. Although there is increasing awareness of the difficulties in coming off psychiatric drugs, with antidepressants receiving attention in research and services, the effects of coming …

Special issue on Withdrawal from Prescribed Psychotropic Drugs

The Winter 2020 issue of the Journal of Critical Psychology, Counselling and Psychotherapy (JCPCP, 20,4), edited by Peter Lehmann, is a special issue on Withdrawal from Prescribed Psychotropic Drugs. It features articles on Medically unexplained symptoms and Functional neurological disorders Minimum dosage and monitoring of neuroleptics Recovering compensation for psychiatric withdrawal harm through litigation  Internationally known authors …

An Open Letter to NICE in the UK

Professor John Read, Chairperson of the Board of the International Institute for Psychiatric Drug Withdrawal has sent an open letter to Paul Chrisp, Director of the Centre for Guidelines, National Institute for Health and Care Excellence (NICE) in the UK. To: Paul Chrisp –  Director, Centre for Guidelines, National Institute for Health and Care Excellence  …

New paper on stopping antipsychotics is deemed a historic breakthrough

A new paper published in Schizophrenia Bulletin by Mark Horowitz, Sameer Jauhar, Sridhar Natesan, Robin Murray and David Taylor shows how extremely slow tapering off antipsychotics over months or years could reduce the potential negative experiences associated with antipsychotic withdrawal. The paper has been described as a ‘historic breakthrough’ in a recent article in the …

Open Excellence Foundation supports IIPDW’s work

The International Institute of Psychiatric Drug Withdrawal has received a microgrant from Open Excellence to support us to continue our work. The grant will support us to design and deliver a training on psychiatric drug withdrawal in collaboration with clinicians, researchers and people with lived experience. It will also allow the Institute to support people …

‘What I have learned from helping thousands of patients taper’

A new article published in Therapeutic Advances in Psychopharmacology provides a clear and accessible summary of what Adele Framer has learned from helping thousands of patients taper their antidepressants and other psychotropic medications, in her role as founder and operator of the online peer-support forum SurvivingAntidepressants.org. Although psychiatric drug withdrawal syndromes have been recognised since the …

Online UK Training Video for Psychological Therapists

These free presentations (3 hours CPD) by the main editors of the Guidance for Psychological Therapists are based on the companion publication “A short guide to what every psychological therapist should know about working with psychiatric drugs”. You can access the presentations here: https://prescribeddrug.info/training/ The presentations, which are each followed by a Q&A session are: Dr James Davies: Context …

Important new study on antipsychotic use and recovery rates

A new study by Martin Harrow, Thomas Jobe, and Liping Tong found that odds of recovery from “serious mental illness” were six times greater if the patient discontinued antipsychotics within two years. The study followed patients with schizophrenia and affective psychosis (bipolar and depression with psychotic features) diagnoses for 20 years. The study was published …